Missouri

In Review:  The Missouri General Assembly concluded its ordinary session for the year.  All PCMA opposed measures were defeated. If you have any questions, please contact Phil Christofanelli at pchristofanelli@pcmanet.org.

In Review: The Missouri Legislature returned from Spring break. HB 982 (anti-PBM omnibus) remains stalled in the House Committee on Administrative Rules. Up Next: The Senate is expected to take up SB 45 (anti-PBM omnibus) on the Floor this week. PCMA is

In Review: The Missouri House of Representatives voted to advance HB 618 (prior authorization) this week. The bill now moves to the State Senate for further consideration. The House Committee on Health voted to advance HB 982/840 (anti-PBM omnibus). The bill has been

In Review: The Missouri House Committee on Insurance voted to advance HB 618 (gold carding). The bill now awaits referral to a Rules Committee for further review.  Up Next: PCMA along with representatives from the industry, will meet with the sponsor

In Review: The Missouri House Committee on Health held a hearing on HBs 982 and 840, anti-PBM omnibus measures including a spread pricing ban, fiduciary mandate, point-of-sale rebates, copay accumulator, and other provisions. PCMA testified in opposition and is working to modify the proposal.

In Review: Today, the Missouri House Committee on Health has scheduled for hearing HBs 982 and HB 840, anti-PBM omnibus measures including a spread pricing ban, fiduciary mandate, and other provisions. PCMA will be present to testify in opposition. The committee will also hear HB

In Review: The Missouri House Committee on Insurance held a hearing on HB 618, a bill to implement gold carding. PCMA submitted testimony in opposition and is collecting feedback from the industry on changes to improve the bill. We will work with

In Review: The Missouri House Committee on Insurance held a hearing on HB 804, a bill to mandate coverage of opioid alternatives. PCMA is working with the sponsor and Committee Chairman to offer limiting language on the proposal. Up Next: Today,

In Review: The Missouri Senate Committee on Health heard two bills, including SB 13 with provisions implementing white bagging, a biosimilar coverage mandate, and prohibitions on disparate treatment of 340B programs. SB 45 is an omnibus anti-PBM bill which includes a spread

In Review: The Missouri Senate Committee on Health will hear two bills of concern on Wednesday. SB 13 includes provisions implementing Any Willing Pharmacy, a biosimilar coverage mandate, and prohibitions on disparate treatment of 340B programs. SB 45 is an omnibus